AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 172 filers reported holding AXSOME THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is 0.32 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,706,854 | -1.0% | 95,963 | +1.8% | 0.02% | 0.0% |
| Q2 2023 | $6,774,817 | +24.0% | 94,278 | +6.5% | 0.02% | +17.6% |
| Q1 2023 | $5,461,456 | -20.2% | 88,545 | -0.2% | 0.02% | -26.1% |
| Q4 2022 | $6,844,439 | +15.9% | 88,739 | -33.6% | 0.02% | +9.5% |
| Q3 2022 | $5,903,000 | +25.7% | 133,705 | +3.9% | 0.02% | +23.5% |
| Q2 2022 | $4,695,000 | -11.8% | 128,677 | -0.0% | 0.02% | +13.3% |
| Q1 2022 | $5,323,000 | +17.0% | 128,692 | +6.9% | 0.02% | +50.0% |
| Q4 2021 | $4,550,000 | +86.6% | 120,440 | +62.8% | 0.01% | +66.7% |
| Q3 2021 | $2,438,000 | -50.9% | 73,969 | +0.5% | 0.01% | -53.8% |
| Q2 2021 | $4,965,000 | +24.1% | 73,598 | +4.2% | 0.01% | +18.2% |
| Q1 2021 | $4,001,000 | -31.9% | 70,664 | -2.0% | 0.01% | -31.2% |
| Q4 2020 | $5,875,000 | +14.7% | 72,107 | +0.3% | 0.02% | -11.1% |
| Q3 2020 | $5,124,000 | +35.4% | 71,910 | +56.3% | 0.02% | +20.0% |
| Q2 2020 | $3,785,000 | +81.1% | 46,005 | +29.5% | 0.02% | +25.0% |
| Q1 2020 | $2,090,000 | – | 35,521 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 788,263 | $35,172,000 | 44.43% |
| Fairmount Funds Management LLC | 1,896,647 | $84,628,000 | 14.88% |
| ACT CAPITAL MANAGEMENT, LLC | 73,000 | $3,257,000 | 4.50% |
| Ghost Tree Capital, LLC | 300,000 | $13,386,000 | 3.76% |
| Ikarian Capital, LLC | 407,600 | $18,188,000 | 3.62% |
| Paradigm Biocapital Advisors LP | 520,080 | $23,206,000 | 3.09% |
| MORGAN JESS S & CO INC | 78,895 | $3,520,000 | 3.06% |
| PFM Health Sciences, LP | 1,659,733 | $74,057,000 | 2.68% |
| RTW INVESTMENTS, LP | 1,882,164 | $83,982,000 | 1.94% |
| Ghost Tree Capital, LLC | 150,000 | $6,693,000 | 1.88% |